Dietary Microplastics Engage Gut Mechanosensory-Endocrine Signaling to Disrupt Bone Homeostasis

This study reveals that chronic dietary ingestion of microplastics disrupts bone homeostasis by activating gut-derived serotonergic signaling through mechanosensory adaptations in enteroendocrine cells, leading to trabecular bone loss without inducing systemic inflammation or intestinal pathology.

The Gist

The Big Picture: Plastic in Our Food is Messing with Our Bones

Imagine your body is a highly sophisticated city. The bones are the skyscrapers and bridges that hold everything up. The gut is the city's main port and customs office, where everything we eat comes in.

For a long time, scientists knew that tiny bits of plastic (microplastics) were everywhere—in the ocean, in the air, and even in our food. But they mostly thought of plastic as "inert," like a rock that just sits there doing nothing.

This new study says: No, plastic isn't just a rock. It's a sneaky troublemaker.

The researchers found that when we eat food contaminated with tiny plastic particles, those particles don't just pass through. They trigger a chain reaction in our gut that confuses our body's "construction crews," leading to weaker bones.

---

The Story of the Experiment

The scientists decided to test this on mice, but they did it in a very realistic way. Instead of force-feeding the mice plastic (which is like shoving a brick down a throat), they mixed the plastic into the mice's actual food. They fed some mice a standard diet, some a high-fat "junk food" diet, and some a high-fiber "healthy" diet, with or without the plastic.

The Result:
The mice didn't get sick in the usual way. They didn't have stomach aches, fevers, or inflamed guts. You couldn't tell they were sick just by looking at their stomachs.

But here's the twist: Their bones were crumbling. Specifically, the spongy, honeycomb-like part of the bone (the trabecular bone) was getting weaker and more fragile. It was like the steel beams inside a skyscraper were rusting away, even though the outside of the building looked fine.

The "Secret Messenger" Analogy

So, how does plastic in the stomach break bones in the leg? The answer lies in a messenger system.

1. The Gut's Alarm System: Inside your gut, there are special cells called Enterochromaffin cells. Think of these as the "sensors" or "security guards" of the gut. Their job is to feel what's happening inside (like pressure from food) and send messages to the rest of the body.
2. The Plastic Confusion: When the plastic particles rub against these sensors, the sensors get confused. They think, "Whoa, there's a lot of pressure here! Something is wrong!"
3. The Wrong Message: Instead of sending a "digestion" signal, these sensors start screaming a different message: "Release Serotonin!"
   • Note: You probably know serotonin as the "happy chemical" in your brain. But in your gut, it acts like a brake pedal for your bones.
4. The Bone Construction Site: High levels of serotonin travel through the blood to the bones. There, it tells the bone-building workers (osteoblasts) to stop working.
   • Analogy: Imagine a construction crew building a bridge. Suddenly, a loud siren (serotonin) goes off, and the foreman yells, "Stop! Put down your hammers! We're done!" The construction stops, and the bridge starts to crumble.

Why Didn't the Gut Get Sick?

You might wonder, "If plastic is rubbing against the gut, why isn't it inflamed?"

The study found that the plastic wasn't causing a fire (inflammation). Instead, it was causing a glitch in the software. The sensors were working too well or were hypersensitive to the plastic, sending the wrong signal (too much serotonin) without actually damaging the gut lining. It's like a smoke detector that goes off because of a burnt piece of toast, even though there is no fire.

The Human Connection

The researchers didn't just stop at mice. They looked at actual human bone samples (from donors who didn't have artificial joints).

• The Discovery: They found tiny plastic particles stuck inside the human bone tissue itself.
• The Lab Test: When they took human bone cells and exposed them to plastic or high levels of serotonin in a petri dish, the cells stopped building bone.

This suggests that the same thing happening in the mice might be happening in us. We are eating plastic, it's confusing our gut sensors, and our bones are getting weaker as a result.

The "Diet" Factor

Interestingly, the study showed that what you eat alongside the plastic matters.

• In mice on a standard diet, the plastic caused the most bone loss.
• In mice on a high-fat or high-fiber diet, the effect was different (sometimes less severe, sometimes different).
• Takeaway: Your overall diet changes how your body reacts to plastic, just like how a car handles differently on ice versus dry pavement.

The Bottom Line

This paper tells us that microplastics are not just physical trash; they are biological disruptors.

They act like a hijacker in our gut's communication system. They trick our body into releasing a chemical (serotonin) that tells our bones to stop building themselves. Even though we don't feel sick, our skeleton is quietly losing its strength.

In short: The plastic in our food is whispering to our gut, "Stop building," and our bones are listening.

Technical Summary

1. Problem Statement

Microplastics (MPs) are pervasive environmental contaminants increasingly found in the human diet. While previous studies have linked MPs to skeletal dysfunction, they suffer from significant limitations:

• Exposure Paradigms: Most prior research relied on non-physiological delivery methods (e.g., intraperitoneal injection or bolus oral gavage) rather than chronic dietary intake.
• Mechanistic Gaps: Existing hypotheses focus on systemic inflammation or direct marrow toxicity, often overlooking the gut-endocrine axis.
• Clinical Relevance: It remains unclear if MPs accumulate in human bone under non-iatrogenic conditions (i.e., without prosthetic implants) and how dietary composition modulates MP toxicity.

2. Methodology

The study employed a multi-modal approach combining in vivo murine models, ex vivo human tissue analysis, in vitro cell culture, and single-cell genomics.

• Animal Model: Adolescent C57BL/6J mice (male and female) were fed three distinct diets for 12 weeks:
  1. AIN: Basal purified diet.
  2. HFC: High-fat, high-cholesterol diet.
  3. FIB: High-fiber diet.
  • Each diet was administered with or without a physiologically relevant mixture of polystyrene (PS) microplastics (~0.49–5.0 µm; ~1.7 mg/kg).
• Phenotyping:
  • Bone Analysis: Dual-energy X-ray absorptiometry (DEXA) for whole-body bone mineral density (BMD) and high-resolution micro-computed tomography (µCT) for femoral and vertebral microarchitecture (trabecular and cortical compartments).
  • Histopathology: Colon histology, fecal lipocalin-2 (LCN2), and secretory IgA (sIgA) to assess gut inflammation and barrier integrity.
  • Hormonal Profiling: Plasma analysis of gut-derived hormones (Serotonin, GIP, GLP-1, Resistin) and inflammatory cytokines (TNFα, MCP-1, IL-6).
• Mechanistic Investigations:
  • Organoid Culture: Colonic organoids from AIN and AMP (AIN + MPs) mice to assess enteroendocrine cell (EEC) differentiation.
  • Reporter Mice: Use of Piezo2-GFP reporter mice to visualize mechanosensory enterochromaffin cells.
  • Single-Nuclei RNA Sequencing (snRNA-seq): Performed on colonic tissue to resolve cell-type-specific transcriptional changes in epithelial, neuronal, and immune compartments.
  • Human Tissue Analysis: Histological sections of human distal femurs (from donors without prosthetics) stained with a conjugated polymer nanoparticle-based dye to detect MPs.
  • In Vitro Assays: Primary human osteoblasts from three donors were exposed to PS MPs and serotonin to assess mineralization capacity.

3. Key Contributions

• Physiological Relevance: Established a chronic dietary exposure model that mimics human ingestion, revealing that MP effects are highly dependent on diet composition and sex.
• Novel Pathway Identification: Discovered a gut-bone endocrine axis where MPs disrupt bone homeostasis via mechanosensory-activated serotonergic signaling, rather than through overt inflammation or direct marrow toxicity.
• Human Evidence: Provided the first evidence of microplastic accumulation in mineralized human bone tissue from individuals without orthopedic implants.
• Mechanistic Resolution: Utilized snRNA-seq to pinpoint that MPs enhance the activity of enterochromaffin cells (EECs) via mechanosensory pathways (Piezo2) without altering cell lineage or causing inflammation.

4. Key Results

A. Skeletal Phenotypes

• Bone Loss: Chronic MP ingestion caused significant bone loss, predominantly affecting the trabecular compartment.
  • AMP Females: Showed both cortical and trabecular deficits (reduced BV/TV, connectivity, cortical area) and upregulation of Dkk1 (Wnt inhibitor) and Il1a.
  • AMP Males: Showed isolated trabecular deterioration with reduced Runx2 (indicating impaired osteoblast differentiation).
• Diet Modulation:
  • High-Fat (HMP): Mitigated bone loss in females but caused trabecular loss in males.
  • High-Fiber (FMP): Did not protect against bone loss; FMP males showed deficits in both cortical and trabecular compartments.
• Absence of Inflammation: No significant colonic pathology, epithelial injury, or systemic elevation of inflammatory cytokines (TNFα, IL-6) was observed, ruling out inflammation as the primary driver.

B. Gut-Endocrine Mechanism

• Serotonin Elevation: MP exposure selectively increased circulating serotonin (5-HT) levels, but only in mice fed the basal AIN diet (AMP group). This correlated with the most severe bone loss.
• EEC Activity:
  • Immunofluorescence showed an increase in CHGA+ and 5-HT+ cells in the colon of AMP mice.
  • No Lineage Reprogramming: Organoid and snRNA-seq data confirmed that the number of enterochromaffin cells did not significantly increase, nor was there a shift in lineage markers.
  • Mechanosensory Activation: snRNA-seq revealed a specific upregulation of Piezo2 (a mechanosensitive ion channel) transcripts in enterochromaffin cells. This suggests MPs act as a mechanical stimulus, enhancing the secretory output of existing EECs.
  • Neuronal Response: A trend toward increased Htr3a (serotonin receptor) expression in enteric neurons suggested enhanced downstream sensitivity to serotonin.

C. Human and In Vitro Validation

• Human Bone: Polymer-specific staining confirmed the presence of microplastics in the mineralized bone of human donors without prosthetics.
• Osteoblast Sensitivity: In vitro, PS MPs and serotonin impaired mineralization in primary human osteoblasts from two of three donors (aged 70s), while a donor in their 60s showed resistance. This highlights donor-dependent variability in susceptibility.

5. Significance

This study fundamentally shifts the understanding of microplastic toxicity:

1. Bioactive Contaminants: MPs are not inert; they act as bioactive dietary constituents that trigger specific physiological signaling pathways.
2. Gut-Bone Axis: It identifies the gut endocrine system, specifically mechanosensory enterochromaffin cells, as a critical interface linking environmental plastic exposure to skeletal health.
3. Clinical Implications: The detection of MPs in human bone and the demonstration of donor-dependent osteoblast sensitivity suggest that chronic environmental MP exposure is an underappreciated risk factor for bone fragility and osteoporosis, particularly in aging populations.
4. Therapeutic Targets: The findings suggest that modulating gut-derived serotonin or mechanosensory pathways (e.g., Piezo2) could be a strategy to mitigate MP-induced bone loss.

Conclusion: The paper establishes that dietary microplastics disrupt bone homeostasis by engaging a gut-derived serotonergic signaling pathway via mechanosensory activation of enterochromaffin cells, operating independently of systemic inflammation. This pathway is modulated by diet and sex, with significant implications for human skeletal health.